The purpose of this study is to evaluate the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
256
for dosage
SKChemicals invetigational site
Seoul, South Korea
ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)
Time frame: 30 minutes
CIBIC-Plus (Clinician's Interview-Based Impression of Change-Plus caregiver input)
Time frame: 45 minutes
MMSE (Mini Mental State Examination)
Time frame: 10 minutes
CDR-SB (Clinical Dementia Rating Sum of Box)
Time frame: 20 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.